Atlas Trials

Quality of Life, Functional and Cognitive Outcomes in Patients With Metastatic Hormone-Sensitive Prostate Cancer

Clinical trial NCT07181122 · RECRUITING

Trial details

NCT number
NCT07181122
Sponsor
Ankara Etlik City Hospital
Status
RECRUITING
Study type
OBSERVATIONAL
Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)
Start date
2025-10-22
Primary completion
2026-04-26
Enrollment
102

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.